11 |
GLYCIKAM SR G1 |
METFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 1 MG |
TABLET |
ALU-ALU BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE. |
No |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5798/24 |
2024-09-25 |
2029-09-24 |
View |
12 |
KANOLONE |
TRIAMCINOLONE ACETONIDE 1 MG |
CREAM |
SACHET, TUBE |
KANOLONE PROVIDES PROMPT RELIEF FROM ORAL TENDERNESS , PAIN, INFLAMMATION AND ULCERATION |
No |
1688 MEDICAL IMPORT-EXPORT SOLE CO.,LTD |
L.B.S.LABORATORY LTD.,PART. |
THAILAND |
CERTIFICATE RELEASED |
11 I 4847/11 |
2024-07-09 |
2027-07-08 |
View |
13 |
ALLORA 5 |
DELSORATADINE 5MG |
FILM COATED TABLET |
ALU-ALU |
IN ADULT AND ADOLESCENTS AGED 12 YEARS AND OLDER FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH ALLERGIC RHINITIS AND URTICARIA. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5286/22 |
2022-10-14 |
2025-10-13 |
View |
14 |
AMIPAREN-10 |
L-TYROSINE 0.10 G, L-ASPARTIC ACID 0.20 G, L-GLUTAMIC ACID 0.20G, L-SERINE 0.60G, L-HISTIDINE 1G, L-PROLINE 1G, L-THREONINE 1.14G, L-PHENYLALANINE 1.40G, L-ISOLEUCINE 1.60G, L-VALINE 1.60G, L-ALANINE 1.60G, L-ARGININE 2.10 G, L-LEUCINE 2.80G, GLYCINE 1.18G, L-LYSINE ACETATE 2.96G, L-METHIONINE 0.78G, L-TRYPTOPHAN 0.40G, L-CYSTEINE 0.2G/200 ML |
SOLUTION FOR INFUSION |
BOTTLE |
FOR PROVIDING AMINO ACIDS IN THE FOLLOWING CASES: HYPOPROTEINEMIA, MALNUTRITION, BEFORE AND AFTER SURGERY. |
No |
AI KEN PHARMA CO., LTD |
OTSUKA PHARMACEUTICAL VIETNAM JSC |
VIETNAM |
CERTIFICATE RELEASED |
05 I 5741/24 |
2024-05-24 |
2027-05-23 |
View |
15 |
AMIYU |
EACH 2.5 G SACHET CONTAINS: L-ISOLEUCINE 203.9MG, L-LEUCINE 320.3MG, L-LYSINE HYDROCHLORIDE 291.0 MG,L-METHIONINE 320.3, L-PHENYLALANINE 320.3 MG,L-THREONINE 145.7 MG, L-TRYPTOPHAN 72.9 MG, L-VALINE 233.0 MG, L-HISTIDINE HYDROCHLORIDE HYDRATE 216.2 MG |
GRANULES |
SACHET |
SUPPLY OF AMINO ACIDS IN CHRONIC RENAL FAILURE |
No |
AI KEN PHARMA CO., LTD |
EA PHARMA CO.,LTD. FUKUSHIMA PLANT |
JAPAN |
CERTIFICATE RELEASED |
04 I 4415/18 |
2024-09-25 |
2029-09-24 |
View |
16 |
ESOPRAZOLE 40 |
ESOMEPRAZOLE MAGNESIUM EQ.TO ESOMEPRAZOLE USP 40 MG |
CAPSULE |
ALU-ALU BLISTER |
GASTRO-OESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX OESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED OESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, HEALING OF GASTRIC ULCERS ASSOCIATED WITH NSAID THERAPY, PREVENTION OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NSAID THERAPY IN PATIENTS AT RISK, HEALING OF HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER |
No |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5863/25 |
2025-01-31 |
2030-01-30 |
View |
17 |
FERROKAM XT TOTAL |
FERROUS ASCORBATE EQ.TO ELEMENTAL IRON 100 MG, FOLIC ACID BP 1.1 MG, ZINC SULFATE MONOHYDRATE BP EQ.TO ELEMENTAL ZINCE 22.5 MG, METHYLCOBALAMIN 1.5 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TO TREAT AND PREVENT NUTRITIONAL DEFICIENCIES SUCH AS IRON DEFICIENCY ANAEMIA |
No |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5864/25 |
2025-01-31 |
2030-01-30 |
View |
18 |
ROSUKAM 20 |
ROSUVASTATIN CALCIUM BP EQ.TO ROSUVASTATIN 20 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TREATMENT OF HYPERCHOLESTEROLAEMIA, PREVENTION OF CARDIOVASCULAR EVENT |
Yes |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5799/24 |
2024-09-25 |
2029-09-24 |
View |
19 |
ROSUKAM 10 |
ROSUVASTATIN CALCIUM BP EQ.TO ROSUVASTATIN 10 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TREATMENT OF HYPERCHOLESTEROLAEMIA, PREVENTION OF CARDIOVASCULAR EVENT |
Yes |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5800/24 |
2024-09-25 |
2029-09-24 |
View |
20 |
ITRAKAM 200 |
ITRACONAZOLE (AS PELLET) 200 MG |
CAPSULE |
ALU-ALU BLISTER |
FOR THE TREATMENT OF THE FOLLOWING FUNGAL INFECTION WHEN THOUGHT LIKELY TO BE SUSCEPTIBLE: VULVOVAGINAL CANDIDIASIS, PITYRIASIS VERSICOLOR, DERMATOPHYTOSE CAUSED BY ORGANISM SUSCEPTIBLE TO ITRACONAZOLE, ORAL CANDIDIASIS, ONYCHOMYCOSIS CAUSED BY DERMATOPHYTE AND /OR YEAST |
No |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5865/25 |
2025-01-31 |
2030-01-30 |
View |